Brunner, Julia S. http://orcid.org/0000-0002-3195-147X
Vulliard, Loan http://orcid.org/0000-0002-2260-4935
Hofmann, Melanie
Kieler, Markus http://orcid.org/0000-0002-4082-5731
Lercher, Alexander http://orcid.org/0000-0003-3478-5304
Vogel, Andrea http://orcid.org/0000-0002-2613-140X
Russier, Marion
Brüggenthies, Johanna B.
Kerndl, Martina http://orcid.org/0000-0001-5060-8944
Saferding, Victoria
Niederreiter, Birgit
Junza, Alexandra
Frauenstein, Annika
Scholtysek, Carina
Mikami, Yohei http://orcid.org/0000-0001-5104-4415
Klavins, Kristaps
Krönke, Gerhard
Bergthaler, Andreas http://orcid.org/0000-0003-0597-1976
O’Shea, John J.
Weichhart, Thomas http://orcid.org/0000-0002-4349-0797
Meissner, Felix http://orcid.org/0000-0003-1000-7989
Smolen, Josef S. http://orcid.org/0000-0002-4302-8877
Cheng, Paul
Yanes, Oscar http://orcid.org/0000-0003-3695-7157
Menche, Jörg http://orcid.org/0000-0002-1583-6404
Murray, Peter J.
Sharif, Omar http://orcid.org/0000-0001-7899-2343
Blüml, Stephan http://orcid.org/0000-0002-2758-4400
Schabbauer, Gernot
Article History
Received: 22 March 2019
Accepted: 16 December 2019
First Online: 22 January 2020
Competing interests
: The authors declare the following competing interests: P.C. is the founder of Biocancer Treatment International Ltd. P.C., G.S. and S.B. are listed as inventors on a patent (US9789169B2) covering recArg1/BCT-100. The remaining authors declare no competing interests.